top of page

Researchers are developing a new kind of Zika virus vaccine

Zika virus has existed since 1947, but it made international headlines during the 2015-2016 outbreak. Despite its notoriety and long history, researchers have not been able to develop an effective vaccine against the disease.


Fortunately, now there’s hope. Enesi Pharma, in a partnership with the University of Adelaide, has received a $1.35 million grant to develop what seems to be a promising vaccine.


This is especially good news at a time when funding for non-COVID-related medical research

has been at an all-time low.


Not only would the vaccine be the first of its kind in terms of protecting against Zika virus; it would also be the world’s first vaccine that doesn’t use a needle.


Instead, a small implant is injected beneath a patient’s skin. The implant will dissolve over time, and spread through the body.


Thanks to funding, the vaccine can now begin phase 1 clinical trials.


Read on to learn more about the needleless vaccine that will hopefully end Zika virus.




Image source



Contact Our Writer – Alysa Salzberg

7 views0 comments

Recent Posts

See All
bottom of page